MET (MetLife) Stock Based Compensation: $0 Mil (TTM As of Mar. 2026)


MET MetLife Inc MET
76 GF Score
Price $91.67
GF Value $90.08
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is MetLife Stock Based Compensation?

MetLife MET +1.34% 76 Stock Based Compensation is $0 Mil as of Mar. 2026. GuruFocus rates MET with a GF Score™ of 76/100 and a GF Value™ of $90.08 (Fairly Valued). The stock has 8 warning signs investors should review.

MetLife's Stock Based Compensation for the three months ended in Mar. 2026 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

MetLife Stock Based Compensation Related Terms

MetLife Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MetLife's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetLife Stock Based Compensation Chart

MetLife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MetLife Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MET
76GF Score
MetLife Inc MET
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetLife Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

What does a Stock Based Compensation of $0 Mil mean?
MetLife (MET) has a Stock Based Compensation of $0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MetLife and its competitors.
Is MetLife's Stock Based Compensation too high?
MetLife's current Stock Based Compensation is $0 Mil. Overall, MetLife has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's Stock Based Compensation compare to AFL and PRU?
MetLife's Stock Based Compensation of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for an Insurance company?
A good Stock Based Compensation depends on the Insurance industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MetLife and its competitors. MetLife's current Stock Based Compensation is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $90.08, compared to a current price of $91.67 — trading 1.8% above its estimated fair value. The current Stock Based Compensation is $0 Mil. MetLife's overall GF Score™ is 76/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MetLife (MET), the current Stock Based Compensation is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MetLife (MET) Overvalued in 2026?

Based on GuruFocus' analysis, MetLife stock appears to be overvalued. The current stock price of $91.67 is trading 1.8% above its estimated GF Value™ of $90.08. GuruFocus considers MetLife to be Fairly Valued.

Key valuation signals for MET:

  • Stock Based Compensation: $0 Mil
  • GF Value™: $90.08 vs. price of $91.67 (1.8% above fair value)
  • GF Score™: 76/100 with 8 warning signs

No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MetLife Business Description

Address 200 Park Avenue, New York, NY, USA, 10166-0188
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
76GF Score

Get the complete analysis for MET

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$91.67
Price
$90.08
GF Value